The discovery and development of IP3 receptor modulators: an update-Reference-Cited by-同舟云学术

The discovery and development of IP3 receptor modulators: an update

Published:2021-01-06 Issue:6 Volume:16 Page:709-718
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Gambardella Jessica¹²³⁴,Morelli Marco B.¹²,Wang Xujun¹,Castellanos Vanessa¹,Mone Pasquale⁵,Santulli Gaetano¹²³⁴^ORCID

Affiliation:

1. Department of Medicine (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, Montefiore University Hospital, New York City, USA

2. Department of Molecular Pharmacology, Fleischer Institute for Diabetes and Metabolism, Einstein-Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York City, USA

3. Department of Advanced Biomedical Sciences, “Federico II” University, Naples, Italy

4. International Translational Research and Medical Education (ITME), Naples, Italy

5. University of Campania “Luigi Vanvitelli”, Naples, Italy

Funder

National Institutes of Health via the National Heart Lung and Blood Institute

the National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2021.1858792